Concepedia

Publication | Open Access

Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma

DOIFull Paper Access

42

Citations

38

References

2013

Year

Roxana Dronca, Jacob B. Allred, Domingo G. Pérez, Wendy K. Nevala, Elizabeth Ann T. Lieser, Michael A. Thompson, William J. Maples, Edward T. Creagan, Barbara A. Pockaj, Judith S. Kaur,
American Journal of Clinical Oncology

Abstract

The combination of TMZ and RAD001 was well tolerated but failed to meet/exceed our study threshold for promising clinical activity in patients with metastatic melanoma.

References

YearCitations

Page 1